EUVIMEDEUVIMED entdecken
Klinische StudieLeserbriefOpen Access

Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study

Nayha Shetty, Rebecca L Quiñonez iD, Marissa S Ceresnie, Sunita Ghosh, Henry W Lim iD, Tasneem F Mohammad

Photochemistry and Photobiology · 2026

DOI: 10.1111/php.70081 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Photochemistry and Photobiology, 2026. Verfasst von Nayha Shetty und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Henry W. Lim, MD, Division of Photobiology and Photomedicine, Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Plant Extracts, Polypodium, Protoporphyria, Erythropoietic. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erythropoietic protoporphyria (EPP) and X‐linked protoporphyria (XLP) cause severe photosensitivity, resulting in significant quality of life (QoL) impairment. This study aims to evaluate the safety and efficacy of Polypodium leucotomos extract (PLE) as an adjunctive therapy in patients with persistent symptoms despite standard dosing of afamelanotide. In this prospective single‐center cohort study, eight adults with confirmed EPP or XLP and ongoing symptoms despite regular afamelanotide implants every 2 months were enrolled. Participants received 480 mg oral PLE daily for 4 months. QoL and symptom severity were measured using questionnaires at baseline, Day 60, and Day 120. Six participants completed the study. Statistically significant improvements in QoL were observed on Day 60 ( p = 0.014), but not at Day 120 ( p = 0.152). Half of participants reported reduced reaction severity. No adverse events occurred. Adjunctive PLE improved short‐term QoL in participants with incomplete symptom control on afamelanotide alone and was well tolerated. Larger studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsPolypodiumProtoporphyria, ErythropoieticAdultFemaleHumansMaleMiddle AgedProspective StudiesQuality of Lifealpha-MSH

Substanzen

afamelanotidePlant Extractsalpha-MSH

Autor:innen und Institutionen

  • The Henry W. Lim, MD, Division of Photobiology and Photomedicine, Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
  • Health Education Services/Lake Granbury Medical Center Dermatology Residency Program, Dallas, Texas, USA.
  • Department of Public Health Science, Henry Ford Health, Detroit, Michigan, USA.
  • Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI, USA.

ORCID-Profile: Rebecca L Quiñonez, Henry W Lim

Zitieren

APA

Shetty, N., Quiñonez, R. L., Ceresnie, M. S., Ghosh, S., Lim, H. W., & Mohammad, T. F. (2026). Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study. Photochemistry and Photobiology. https://doi.org/10.1111/php.70081

Vancouver

Shetty N, Quiñonez RL, Ceresnie MS, Ghosh S, Lim HW, Mohammad TF. Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study. Photochemistry and Photobiology. 2026. doi:10.1111/php.70081

BibTeX
@article{Shetty2026,
  author = {Shetty, Nayha and Quiñonez, Rebecca L and Ceresnie, Marissa S and Ghosh, Sunita and Lim, Henry W and Mohammad, Tasneem F},
  title = {Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study},
  journal = {Photochemistry and Photobiology},
  year = {2026},
  doi = {10.1111/php.70081}
}
Kostenlos starten →